Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
A brain tumor is always a very serious matter, and a thalamic or hypothalamic astrocytoma is no exception. A thalamic/hypothalamic astrocytoma is a low-grade, slow-growing glioma (brain tumor) that arises in either the thalamus, the hypothalamus or both.
In the next tabs, you’ll find more detailed information about thalamic/hypothalamic astrocytomas. To read more general information about brain tumors first, see our overview on brain tumors.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches thalamic/hypothalamic astrocytomas
If your child is cared for at Boston Children’s, she will be seen at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center through our Glioma Program. Continue reading to learn more about thalamic or hypothalamic astrocystomas or visit the Glioma Program homepage to learn about our expertise and treatment options for this condition.
After treatment, your child will receive expert follow-up care through our childhood brain tumor survivorship program within the Stop & Shop Family Pediatric Neuro-Oncology Outcomes Clinic, where she can meet with her neurosurgeon, radiation oncologist, pediatric neuro-oncologist and neurologists at the same follow-up visit.
The largest predictor of how a child will do in an operation is not based on where the tumor is located or how big it is. The No. 1 predictor is how experienced the neurosurgeon is in doing that operation in children.
----Mark Kieran, MD, PhD, director of the Pediatric Brain Tumor Program
Reviewed by Susan Chi, MD
Boston Children’s Hospital, 2013
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”